{"id":"https://openalex.org/W2043615792","doi":"https://doi.org/10.1007/bf00444698","title":"Activation in young rats induced by LY134046, an inhibitor of phenylethanolamine N-methyltransferase","display_name":"Activation in young rats induced by LY134046, an inhibitor of phenylethanolamine N-methyltransferase","publication_year":1989,"publication_date":"1989-06-01","ids":{"openalex":"https://openalex.org/W2043615792","doi":"https://doi.org/10.1007/bf00444698","mag":"2043615792","pmid":"https://pubmed.ncbi.nlm.nih.gov/2502794"},"language":"en","primary_location":{"id":"doi:10.1007/bf00444698","doi":"https://doi.org/10.1007/bf00444698","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00444698","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054758876","display_name":"Ivan N. Mefford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ivan N. Mefford","raw_affiliation_strings":["Section on Clinical Pharmacology, Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD 20892","Section on Clinical Pharmacology, Laboratory of Clinical Science, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section on Clinical Pharmacology, Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I4210158500"]},{"raw_affiliation_string":"Section on Clinical Pharmacology, Laboratory of Clinical Science, Bethesda, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073565233","display_name":"Alice L. Lawrenz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alice L. Lawrenz","raw_affiliation_strings":["Section on Clinical Pharmacology, Laboratory of Clinical Science, Building 10, Room 2D46, 9000 Rockville Pike, 20892, Bethesda, MD, USA","Section on Clinical Pharmacology, Laboratory of Clinical Science, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section on Clinical Pharmacology, Laboratory of Clinical Science, Building 10, Room 2D46, 9000 Rockville Pike, 20892, Bethesda, MD, USA","institution_ids":[]},{"raw_affiliation_string":"Section on Clinical Pharmacology, Laboratory of Clinical Science, Bethesda, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036507830","display_name":"John Hsiao","orcid":"https://orcid.org/0000-0003-3471-7539","observed_orcids":["https://orcid.org/0000-0003-3471-7539"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John K. Hsiao","raw_affiliation_strings":["Section on Clinical Pharmacology, Laboratory of Clinical Science, Building 10, Room 2D46, 9000 Rockville Pike, 20892, Bethesda, MD, USA","Section on Clinical Pharmacology, Laboratory of Clinical Science, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section on Clinical Pharmacology, Laboratory of Clinical Science, Building 10, Room 2D46, 9000 Rockville Pike, 20892, Bethesda, MD, USA","institution_ids":[]},{"raw_affiliation_string":"Section on Clinical Pharmacology, Laboratory of Clinical Science, Bethesda, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063501456","display_name":"Jacqueline N. Crawley","orcid":"https://orcid.org/0000-0002-1224-995X","observed_orcids":["https://orcid.org/0000-0002-1224-995X"]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline N. Crawley","raw_affiliation_strings":["Clinical Neuroscience Branch, National Institute of Mental Health, 9000 Rockville Pike, 20892, Bethesda, MD, USA","Clinical Neuroscience Branch, National Institute of Mental Health, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuroscience Branch, National Institute of Mental Health, 9000 Rockville Pike, 20892, Bethesda, MD, USA","institution_ids":["https://openalex.org/I4210158500"]},{"raw_affiliation_string":"Clinical Neuroscience Branch, National Institute of Mental Health, Bethesda, USA","institution_ids":["https://openalex.org/I4210158500"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.2744,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.44358997,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"98","issue":"2","first_page":"240","last_page":"244"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9096999764442444,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9096999764442444,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.06300000101327896,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10985","display_name":"Sleep and Wakefulness Research","score":0.007400000002235174,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/yohimbine","display_name":"yohimbine","score":0.6790000200271606},{"id":"https://openalex.org/keywords/alpha2-adrenergic-receptors","display_name":"alpha2-adrenoceptors","score":0.8600000143051147},{"id":"https://openalex.org/keywords/epinephrine-synthesis","display_name":"epinephrine synthesis","score":0.968999981880188},{"id":"https://openalex.org/keywords/locomotor-activity","display_name":"locomotor activity","score":0.8309999704360962},{"id":"https://openalex.org/keywords/juvenile-rats","display_name":"young rats","score":0.5989999771118164},{"id":"https://openalex.org/keywords/age-effects","display_name":"age effects","score":0.5350000262260437}],"concepts":[{"id":"https://openalex.org/C2779546955","wikidata":"https://www.wikidata.org/wiki/Q411541","display_name":"Phenylethanolamine N-methyltransferase","level":5,"score":0.942872941493988},{"id":"https://openalex.org/C2776804559","wikidata":"https://www.wikidata.org/wiki/Q7181429","display_name":"Phenylethanolamine","level":4,"score":0.8660589456558228},{"id":"https://openalex.org/C2777676773","wikidata":"https://www.wikidata.org/wiki/Q412226","display_name":"Yohimbine","level":4,"score":0.7884231805801392},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6869152188301086},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.642620861530304},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6245713233947754},{"id":"https://openalex.org/C2775859304","wikidata":"https://www.wikidata.org/wiki/Q132621","display_name":"Epinephrine","level":2,"score":0.5816994905471802},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49630528688430786},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.4921993315219879},{"id":"https://openalex.org/C91965660","wikidata":"https://www.wikidata.org/wiki/Q415875","display_name":"Methyltransferase","level":4,"score":0.4539310038089752},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.44612473249435425},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.44083595275878906},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3790631890296936},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3616088628768921},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2284231185913086},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21086785197257996},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.19362235069274902},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.1250152885913849},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10350358486175537},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.06965863704681396},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.054755955934524536},{"id":"https://openalex.org/C159167319","wikidata":"https://www.wikidata.org/wiki/Q420766","display_name":"Tyrosine hydroxylase","level":3,"score":0.05419042706489563},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C171606756","wikidata":"https://www.wikidata.org/wiki/Q506132","display_name":"Psychometrics","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005106","descriptor_name":"Exploratory Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010625","descriptor_name":"Phenylethanolamine N-Methyltransferase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015016","descriptor_name":"Yohimbine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf00444698","doi":"https://doi.org/10.1007/bf00444698","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00444698","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:2502794","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2502794","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W627472209","https://openalex.org/W1949457518","https://openalex.org/W1964274186","https://openalex.org/W1968568694","https://openalex.org/W1972377663","https://openalex.org/W1975080138","https://openalex.org/W1976226020","https://openalex.org/W1979945171","https://openalex.org/W1983661001","https://openalex.org/W1985976867","https://openalex.org/W1991885889","https://openalex.org/W1993834548","https://openalex.org/W1997366630","https://openalex.org/W1998825004","https://openalex.org/W2015939047","https://openalex.org/W2018343193","https://openalex.org/W2023605292","https://openalex.org/W2035595702","https://openalex.org/W2049735743","https://openalex.org/W2049838098","https://openalex.org/W2050794326","https://openalex.org/W2071823161","https://openalex.org/W2073090055","https://openalex.org/W2086096812","https://openalex.org/W2089108617","https://openalex.org/W2090856451","https://openalex.org/W2095138506","https://openalex.org/W2135004468","https://openalex.org/W2138728119"],"related_works":["https://openalex.org/W7100401512","https://openalex.org/W2027676147","https://openalex.org/W2034807935","https://openalex.org/W2013497366","https://openalex.org/W2015939047","https://openalex.org/W1837825123","https://openalex.org/W2065673099","https://openalex.org/W2005165969","https://openalex.org/W81369120","https://openalex.org/W2050794326"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}